Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Finasteride may improve prostate cancer treatment outcomes.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Dutasteride and finasteride affect different cell types differently.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Certain natural compounds called terpenes may help prevent prostate cancer.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Certain genetic markers can indicate a person's risk of developing prostate cancer.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.